Robust correlation of Galectin-9 expression with immunological tumor features and outcome in multiple tumor types establishes it as both a novel therapeutic target and a biomarker

被引：0

作者：

Filipovic, Aleksandra ^{[1
]}

Koide, Shohei ^{[2
]}

Chen, Linxiao ^{[2
]}

Ting, David T. ^{[3
]}

Ilyas, Mohammad ^{[4
]}

Fadhil, Wakkas ^{[4
]}

Rakha, Emad ^{[4
,5
]}

Green, Andrew ^{[4
,5
]}

机构：

[1] PureTech Hlth, Boston, MA USA

[2] NYU, Perlmutter Canc Ctr, New York, NY USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Biodiscovery Inst, Nottingham, England

[5] Nottingham City Hosp, Dept Histopathol, Nottingham, England

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-LB-350

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-350

引用

页数：2

共 6 条

[1] Galectin-9 as a regulator of immune interactions in the tumor microenvironment and novel therapeutic target in biliary tract cancer.
Warren, Emilie A. K.
Hammons, Jacklyn
Keilson, Jessica M.
Wyatt, Megan
Medin, Caroline
Henry, Curtis
Kulkarni, Sarah
Liu, Yuan
Robinson, Brian
Krasinskas, Alyssa
Maithel, Shishir K.
Paulos, Chrystal M.
Lesinski, Gregory B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 555 - 555
[2] Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer
Warren, Emilie A. K.
Hammons, Jacklyn N.
Keilson, Jessica M.
Rivera, Guillermo O. Rangel
Wyatt, Megan M.
Goel, Caroline R.
Henry, Curtis J.
Kulkarni, Sarah
Li, Yuan
Robinson, Brian
Krasinskas, Alyssa M.
Azad, Nilofer S.
Yarchoan, Mark
Maithel, Shishir K.
Paulos, Chrystal M.
Lesinski, Gregory B.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S28 - S28
[3] CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
Jiang, Aimin
Zhou, Ye
Gong, Wenliang
Pan, Xin
Gan, Xinxin
Wu, Zhenjie
Liu, Bing
Qu, Le
Wang, Linhui
[J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
[4] MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
Wu, Szu-Yuan
Lin, Kuan-Chou
Lawal, Bashir
Wu, Alexander T. H.
Wu, Ching-Zong
[J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4970 - 4983
[5] Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
Zhang, Zhenshan
Wu, Leilei
Li, Juan
Chen, Jiayan
Yu, Qi
Yao, Hui
Xu, Yaping
Liu, Liang
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[6] Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
Zhenshan Zhang
Leilei Wu
Juan Li
Jiayan Chen
Qi Yu
Hui Yao
Yaping Xu
Liang Liu
[J]. Journal of Translational Medicine, 20

← 1 →